Lead portfolio growth strategy for the AIIA portfolio (two hypertension brands), translating business ambition into clear brand priorities, positioning, and execution roadmap.
Reshape mature brands by identifying new growth opportunities across customer segmentation, treatment pathways, clinical value communication, and innovative solution.
Own end‑to‑end brand planning and project execution, ensuring all initiatives are aligned with portfolio strategy, commercially impactful, and delivered with discipline.
Generate actionable insights through deep understanding of the hypertension market, hospital practices, HCP needs, and evolving guideline and policy environments.
Lead impactful HCP engagement and omnichannel initiatives, working closely with Commercial, Medical, Digital, and external partners to improve quality of engagement.